Free Float 99,62 %
Shares Float 74,13 M
Shares Outstanding 74,41 M
ALBERT LABS INTL. CORP. Share · CA0127841041 · A3DJEF (XCNQ) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of ALBERT LABS INTL. CORP.
No Price
Share Float & Liquidity
Company Profile for ALBERT LABS INTL. CORP. Share
Albert Labs International Corp. operates as a clinical research and drug development company. The company focuses on treating patients with urgent and unmet needs, including critical mental health indications. It develops psilocybin-assisted therapies to improve mental health conditions, including anxiety, depression, and oncology-related distress. The company is based in Burnaby, Canada.
Company Data
Name ALBERT LABS INTL. CORP.
Company Albert Labs International Corp.
Website
https://albertlabs.com
Primary Exchange 
Frankfurt
Frankfurt
WKN A3DJEF
ISIN CA0127841041
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Navchand Jagpal
Country Canada
Currency EUR
Employees -
Address 6996 Merritt Avenue, V5J 4R6 Burnaby
IPO Date 2023-02-01
Stock Splits
| Date | Split |
|---|---|
| 10.03.2022 | 1:10 |
Ticker Symbols
| Name | Symbol |
|---|---|
| CSE LISTED | ABRT.CN |
| Frankfurt | VB50.F |
More Shares
Investors who hold ALBERT LABS INTL. CORP. also have the following shares in their portfolio:
